Kalp Cerrahisi Gerektiren Durumlar
Özet
Dünyada ölüm nedenlerinin başında yer alan kardiyovasküler hastalıklar, her yıl yaklaşık 17,5 milyon insanın ölümüne neden olmaktadır. Kardiyovasküler hastalıkların yönetiminde ilişkili risk faktörlerini anlamak, sağlıklı yaşam tarzını ve önleyici stratejileri benimsemek ve erken teşhis önemli rol oynarken; hemşirelerin de içinde olduğu multidisipliner bir ekip yaklaşımı uygulanmalıdır.
Cardiovascular diseases, the leading cause of death worldwide, result in the deaths of approximately 17.5 million people each year. While it is important to understand the associated risk factors, adopt a healthy lifestyle, and employ preventive strategies for the management of cardiovascular diseases, a multidisciplinary team approach that includes nurses should be implemented.
Referanslar
World Health Organization. World health statistics 2023: monitoring health for the SDGs, Sustainable Development Goals. 2023. Geneva. 17/06/2023 tarihinde https://www.who.int/publications/i/item/9789240074323 adresinden ulaşılmıştır).
Timmis A, Townsend N, Gale CP, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019 [published correction appears in Eur Heart J. 2020 Dec 14;41(47):4507]. Eur Heart J. 2020;41(1):12-85. doi:10.1093/eurheartj/ehz859.
TÜİK. Ölüm ve ölüm nedeni istatistikleri 2021. Sayı: 45715, Tarih: 23 Şubat 2023. (19/06/2023 tarihinde https://data.tuik.gov.tr/Bulten/Index?p=%C3%96l%C3%BCm-ve-%C3%96l%C3%BCm-Nedeni-%C4%B0statistikleri-2021-45715&dil=1 adresinden ulaşılmıştır).
Onat A, Can G, Yüksel H, ve ark. Türk erişkinlerinde kalp hastalığı ve risk faktörleri (TEKHARF). Tıp Dünyasının Kronik Hastalıklara Yaklaşımına Öncülük. TEKHARF 2017. İstanbul: Logos Yayıncılık. 2017.
Timmis A, Vardas P, Townsend N, et al. European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary. Eur Heart J Qual Care Clin Outcomes. 2022;8(4):377-382. doi:10.1093/ehjqcco/qcac014.
Malakar AK, Choudhury D, Halder B, et al. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol. 2019;234(10):16812-16823. doi:10.1002/jcp.28350.
Ford TJ, Berry C. Angina: contemporary diagnosis and management. Heart. 2020;106(5):387-398. doi:10.1136/heartjnl-2018-314661
National Institute for Health and Care Excellence (NICE). Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis. 2016. London: Nov 30. (NICE Clinical Guidelines, No. 95.) 19/06/2023 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK553650/ adresinden ulaşılmıştır).
Kusu-Orkar TE, Kermali M, Oguamanam N, et al. Coronary artery bypass grafting: Factors affecting outcomes. J Card Surg. 2020;35(12):3503-3511. doi:10.1111/jocs.15013.
Katta N, Loethen T, Lavie CJ, et al. Obesity and coronary heart disease: epidemiology, pathology, and coronary artery ımaging. Curr Probl Cardiol. 2021;46(3):100655. doi:10.1016/j.cpcardiol.2020.100655.
WHO. Cardiovascular diseases (CVDs). 11 June 2021.(18/06/2023 tarihinde https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) adresinden ulaşılmıştır).
Dibben GO, Faulkner J, Oldridge N, et al. Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis. Eur Heart J. 2023;44(6):452-469. doi:10.1093/eurheartj/ehac747.
CDC. Coronary artery disease. (19/06/2023 tarihinde https://www.cdc.gov/heartdisease/coronary_ad.htm#:~:text=Coronary%20artery%20disease%20is%20caused,This%20process%20is%20called%20atherosclerosis adresinden ulaşılmıştır).
John A, Bouillon-Minois JB, Bagheri R, et al. The influence of burnout on cardiovascular disease: a systematic review and meta-analysis. Front Psychiatry. 2024 Feb 19;15:1326745.
Ebong IA, Quesada O, Fonkoue IT, et al; American College of Cardiology Cardiovascular Disease in Women Committee. The Role of Psychosocial Stress on Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Jul 16;84(3):298-314.
Albasheer O, Abdelwahab SI, Zaino MR, et al. The impact of social isolation and loneliness on cardiovascular disease risk factors: a systematic review, meta-analysis, and bibliometric investigation. Sci Rep. 2024 Jun 4;14(1):12871.
Sulava EF, Johnson JC. Management of Coronary Artery Disease. Surg Clin North Am. 2022 Jun;102(3):449-464.
Doenst T, Thiele H, Haasenritter J, et al. The Treatment of Coronary Artery Disease. Dtsch Arztebl Int. 2022 Oct 21;119(42):716-723.
Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–1367.
Karacabay K. Kalp Damar Cerrahisinde Bakım. In: Yavuz van Gıersbergen M (ed). Cerrahi Hemşireliği. Ankara: Ankara Nobel Tıp Kitapevleri; 2023. p. 337.
Fiedler AG, Tolis G Jr. Surgical treatment of valvular heart disease: overview of mechanical and tissue prostheses, advantages, disadvantages, and ımplications for clinical use. Curr Treat Options Cardiovasc Med. 2018;20(1):7. Published 2018 Feb 5. doi:10.1007/s11936-018-0601-7.
Aluru JS, Barsouk A, Saginala K, et al. Valvular heart disease epidemiology. Med Sci (Basel). 2022;10(2):32. Published 2022 Jun 15. doi:10.3390/medsci10020032
Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: A compass for global action. J Am Coll Cardiol. 2020;76(25):2980-2981. doi:10.1016/j.jacc.2020.11.021
Otemuyiwa BT, Lee EM, Sella E, et al. Effects of mitral valve prolapse on quantification of mitral regurgitation and ejection fraction using cardiac MRI. Radiol Cardiothorac Imaging. 2023;5(1):e220069. Published 2023 Feb 16. doi:10.1148/ryct.220069
Shah SN, Gangwani MK, Oliver TI. Mitral Valve Prolapse. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. (19/06/2023 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK470288/ adresinden ulaşılmıştır).
Miller MA, Dukkipati SR, Turagam M, et al. Arrhythmic mitral valve prolapse: JACC review topic of the week. J Am Coll Cardiol. 2018;72(23 Pt A):2904-2914. doi:10.1016/j.jacc.2018.09.048.
Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and Beyond. J Am Coll Cardiol. 2019;74(20):2529-2532. doi:10.1016/j.jacc.2019.10.009
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease [published correction appears in Eur Heart J. 2022 Feb 18]. Eur Heart J. 2022;43(7):561-632. doi:10.1093/eurheartj/ehab395.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: Executive summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2021 Feb 2;143(5):e228] [published correction appears in Circulation. 2021 Mar 9;143(10):e784]. Circulation. 2021;143(5):e35-e71. doi:10.1161/CIR.0000000000000932
Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published correction appears in J Am Coll Cardiol. 2019 May 14;73(18):2361-2362]. J Am Coll Cardiol. 2019;73(12):e81-e192. doi:10.1016/j.jacc.2018.08.1029
Harb SC, Griffin BP. Mitral valve disease: A comprehensive review. Curr Cardiol Rep. 2017;19(8):73. doi:10.1007/s11886-017-0883-5.
Mayoclinic.org. Mitral valve prolapse. (10/07/2023 tarihinde https://www.mayoclinic.org/diseases-conditions/mitral-valve-prolapse/symptoms-causes/syc-20355446#dialogId1520086 adresinden ulaşılmıştır).
Mayoclinic.org. Mitral valve stenosis. (10/07/2023 tarihinde https://www.mayoclinic.org/diseases-conditions/mitral-valve-stenosis/symptoms-causes/syc-20353159#dialogId66510114 adresinden ulaşılmıştır).
Harris C, Croce B, Munkholm-Larsen S. Tricuspid valve disease. Ann Cardiothorac Surg. 2017;6(3):294. doi:10.21037/acs.2017.05.01.
Allie E. Goins, David A. Tate, George A. Tricuspid and Pulmonic Valve Disease. Netter's Cardiology, (2019). 48, 336-340. (12/07/2023 tarihinde https://books.google.com.tr/books?id=fRNkDwAAQBAJ&pg=PR18&lpg=PR18&dq=Allie+E.+Goins,+David&source=bl&ots=qxAKF2LoKK&sig=ACfU3U0h5Ue3xXdoVW-U2tMfRtAn88xJCA&hl=tr&sa=X&ved=2ahUKEwjg9uvOh6GCAxW9RvEDHeeUB6EQ6AF6BAgIEAM#v=onepage&q=Allie%20E.%20Goins%2C%20David&f=false adresinden ulaşılmıştır).
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: A report of the american college of cardiology/american heart association joint committee on clinical practice guidelines [published correction appears in Circulation. 2021 Feb 2;143(5):e228] [published correction appears in Circulation. 2021 Mar 9;143(10):e784]. Circulation. 2021;143(5):e35-e71. doi:10.1161/CIR.0000000000000932.
Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019;12(3):433-442. doi:10.1016/j.jcmg.2018.06.014
Mayoclinic.org. Tricuspid valve regurgitation. (18/07/2023 tarihinde https://www.mayoclinic.org/diseases-conditions/tricuspid-valve-regurgitation/symptoms-causes/syc-20350168#dialogId2055779 adresinden ulaşılmıştır).
Rehman Medical Institute. Tricuspid valve stenosis. (18/07/2023 tarihinde https://rmi.edu.pk/disease/tricuspid-stenosis adresinden ulaşılmıştır).
Brtko M. Aortic regurgitation: From diagnosis to ındication. In: Vojacek J, Zacek P, Dominik J. (eds) Aortic Regurgitation. Springer, Cham. 2018.
Flint N, Wunderlich NC, Shmueli H, et al. Aortic regurgitation. Curr Cardiol Rep. 2019;21(7):65. Published 2019 Jun 3. doi:10.1007/s11886-019-1144-6.
Mayoclinic.org. Aortic valve repair and aortic valve replacement. (24/07/2023 tarihinde https://www.mayoclinic.org/tests-procedures/aortic-valve-repair-aortic-valve-replacement/about/pac-20385093 adresinden ulaşılmıştır).
Gardezi SKM, Myerson SG, Chambers J, et al. Cardiac auscultation poorly predicts the presence of valvular heart disease in asymptomatic primary care patients. Heart. 2018;104(22):1832-1835. doi:10.1136/heartjnl-2018-313082.
Yadgir S, Johnson CO, Aboyans V, et al. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990-2017 [published correction appears in Circulation. 2020 May 26;141(21):e836]. Circulation. 2020;141(21):1670-1680. doi:10.1161/CIRCULATIONAHA.119.043391
Schleich JM, Abdulla T, Summers R, et al. An overview of cardiac morphogenesis. Arch Cardiovasc Dis. 2013;106(11):612-623. doi:10.1016/j.acvd.2013.07.001.
Liu Y, Chen S, Zühlke L, et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455-463. doi:10.1093/ije/dyz009
Sun R, Liu M, Lu L, et al. Congenital heart disease: Causes, diagnosis, symptoms, and treatments. Cell Biochem Biophys. 2015;72(3):857-860. doi:10.1007/s12013-015-0551-6.
Yang H, Pan J, Wang W, et al. Application of artificial ıntelligence-based auxiliary diagnosis in congenital heart disease screening. Anatol J Cardiol. 2023;27(4):205-216. doi:10.14744/AnatolJCardiol.2022.1386
Dakkak W, Oliver TI. Ventricular septal defect. [Updated 2023 Jan 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 (4/08/2023 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK470330/ adresinden ulaşılmıştır).
Mandalenakis Z, Giang KW, Eriksson P, et al. Survival in children with congenital heart disease: Have We Reached a Peak at 97%?. J Am Heart Assoc. 2020;9(22):e017704. doi:10.1161/JAHA.120.017704
Mayoclinic.org. Atrial septal defect (ASD). (06/08/2023 tarihinde https://www.mayoclinic.org/diseases-conditions/atrial-septal-defect/symptoms-causes/syc-20369715 adresinden ulaşılmıştır).
Wang T, Chen L, Yang T, et al. Congenital heart disease and risk of cardiovascular disease: A meta-analysis of cohort studies. J Am Heart Assoc. 2019;8(10):e012030. doi:10.1161/JAHA.119.012030.
Menillo AM, Lee LS, Pearson-Shaver AL. Atrial septal defect. [Updated 2023 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 (16/08/2023 tarihinde https://www.ncbi.nlm.nih.gov/books/NBK535440/ adresinden ulaşılmıştır).
Bradley EA, Zaidi AN. Atrial septal defect. Cardiol Clin. 2020;38(3):317-324. doi:10.1016/j.ccl.2020.04.001.
Morray BH. Ventricular septal defect closure devices, techniques, and outcomes. Interv Cardiol Clin. 2019;8(1):1-10. doi:10.1016/j.iccl.2018.08.002.
Mayoclinic.org. Ventricular septal defect (VSD). (19/08/2023 tarihinde https://www.mayoclinic.org/diseases-conditions/ventricular-septal-defect/symptoms-causes/syc-20353495 adresinden ulaşılmıştır).
Soto B, Becker AE, Moulaert AJ, et al. Classification of ventricular septal defects. Br Heart J. 1980;43(3):332-343. doi:10.1136/hrt.43.3.332
Rao PS, Harris AD. Recent advances in managing septal defects: ventricular septal defects and atrioventricular septal defects. F1000Res. 2018;7:F1000 Faculty Rev-498. Published 2018 Apr 26. doi:10.12688/f1000research.14102.1
